MAPT and Alzheimer disease: While the signal of [11C]Pittsburgh compound B (PiB), one of the most commonly used PET tracer for detecting amyloid plaques, barely changed after the clinical onset of AD, [11C]PBB3 successfully demonstrated spreading of brain tau pathology in transition from normal ageing to moderate AD, suggesting the usefulness of tau PET imaging as an objective index of disease progression [18].